Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  



























Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1Medical uses
 


1.1Use in humans
 




1.2Use in animals
 




1.3Use in laboratory
 






2Mechanism of action
 




3Side effects
 




4See also
 




5References
 













Furazolidone






العربية
تۆرکجه
Cymraeg
Deutsch
Español
فارسی
Italiano
Nederlands

Polski
Română
Русский
Српски / srpski
Srpskohrvatski / српскохрватски
Türkçe
Українська
Tiếng Vit

 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 




In other projects  



Wikimedia Commons
 


















From Wikipedia, the free encyclopedia
 


Furazolidone
Structural formula of furazolidone
Space-filling model of the furazolidone model
Clinical data
AHFS/Drugs.comMicromedex Detailed Consumer Information
Routes of
administration
Oral-Local
ATC code
Identifiers
  • 3-[(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one

CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.000.594 Edit this at Wikidata
Chemical and physical data
FormulaC8H7N3O5
Molar mass225.160 g·mol−1
3D model (JSmol)
  • C1COC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-]

  • InChI=1S/C8H7N3O5/c12-8-10(3-4-15-8)9-5-6-1-2-7(16-6)11(13)14/h1-2,5H,3-4H2 checkY

  • Key:PLHJDBGFXBMTGZ-UHFFFAOYSA-N checkY

 ☒NcheckY (what is this?)  (verify)

Furazolidone is a nitrofuran antibacterial agent and monoamine oxidase inhibitor (MAOI).[1] It is marketed by Roberts Laboratories under the brand name Furoxone and by GlaxoSmithKlineasDependal-M.

Medical uses[edit]

Furazolidone has been used in human and veterinary medicine. It has a broad spectrum of activity, being active against:[citation needed]

Use in humans[edit]

In humans, it has been used to treat diarrhoea and enteritis caused by bacterialorprotozoan infections, including traveler's diarrhoea, cholera, and bacteremic salmonellosis.

From the early 1970s, it has been used in China to treat peptic ulcers, where the mechanism is treatment of the causative Helicobacter pylori infection.[2] In 2002, a journal article suggested its use in treatment of H. pylori infections in children.[3]

Furazolidone has also been used for giardiasis (due to Giardia lamblia), amoebiasis, and shigellosis, also though it is not a first-line treatment.[4]

Use in animals[edit]

As a veterinary medicine, furazolidone has been used with some success to treat salmonids for Myxobolus cerebralis infections.[citation needed]

It has also been used in aquaculture.[5]

Since furazolidone is a nitrofuran antibiotic, its use in food animals is currently prohibited by the FDA under the Animal Medicinal Drug Use Clarification Act, 1994.[6]

Furazolidone is no longer available in the US.[citation needed]

Use in laboratory[edit]

It is used to differentiate micrococci and staphylococci.[citation needed]

Mechanism of action[edit]

It is believed to work by crosslinking of DNA.[7]

Side effects[edit]

Though an effective antibiotic when all others fail, against extremely drug resistant infections, it has many side effects. including inhibition of monoamine oxidase,[1] and as with other nitrofurans generally, minimum inhibitory concentrations also produce systemic toxicity, resulting in tremors, convulsions, peripheral neuritis, gastrointestinal disturbances, and depression of spermatogenesis. Nitrofurans are recognized by FDA as mutagens/carcinogens, and can no longer be used as of 1991.[8]

See also[edit]

References[edit]

  1. ^ a b Timperio AM, Kuiper HA, Zolla L (February 2003). "Identification of a furazolidone metabolite responsible for the inhibition of amino oxidases". Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 33 (2): 153–167. doi:10.1080/0049825021000038459. PMID 12623758. S2CID 35868007.
  • ^ Xiao SD (2002). "How we discovered in Cina in 1972 that antibiotics cure peptic ulcer.". Helicobacter Pioneers: Firsthand Accounts from the Scientists Who Discovered Helicobacters, 1893-1983. Wiley. pp. 99–104. ISBN 978-0-86793-035-1.
  • ^ Machado RS, Silva MR, Viriato A (2008). "Furazolidone, tetracycline and omeprazole: a low-cost alternative for Helicobacter pylori eradication in children". Jornal de Pediatria. 84 (2): 160–165. doi:10.2223/JPED.1772. PMID 18372934.
  • ^ Petri WA (February 2005). "Treatment of Giardiasis". Current Treatment Options in Gastroenterology. 8 (1): 13–17. doi:10.1007/s11938-005-0047-3. PMID 15625030. S2CID 22893579.
  • ^ Meng J, Mangat SS, Grudzinski IP, Law FC (1998). "Evidence of 14C-furazolidone metabolite binding to the hepatic DNA of trout". Drug Metabolism and Drug Interactions. 14 (4): 209–219. doi:10.1515/DMDI.1998.14.4.209. PMID 10694929. S2CID 20792443.
  • ^ Bagley C. "Drugs Prohibited from Extralabel Use in Animals". Utah State University Extension. Archived from the original on 16 April 2014. Retrieved 14 April 2014.
  • ^ "Furazolidone (DB00614)". DrugBank. Retrieved 2008-12-19.
  • ^ "Declaring a Ban/Phase-Out of the Use of Nitrofurans in Food-Producing Animals". Department of Health, Department of Agriculture. Republic of the Philippines. 17 August 2000. Archived from the original on September 24, 2007.

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=Furazolidone&oldid=1217103208"

    Categories: 
    Acetaldehyde dehydrogenase inhibitors
    Antibiotics
    Antiprotozoal agents
    Nitrofurans
    Monoamine oxidase inhibitors
    2-Oxazolidinones
    Hydrazones
    Hidden categories: 
    Articles with short description
    Short description matches Wikidata
    Articles with changed KEGG identifier
    Articles with changed EBI identifier
    ECHA InfoCard ID from Wikidata
    Drugs with no legal status
    Drugboxes which contain changes to verified fields
    Drugboxes which contain changes to watched fields
    All articles with unsourced statements
    Articles with unsourced statements from December 2022
    Articles with unsourced statements from February 2023
    Articles with unsourced statements from June 2021
     



    This page was last edited on 3 April 2024, at 21:15 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki